Fritsche HA - Search Results

1

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ. Nakanishi H, et al. Among authors: fritsche ha. J Urol. 2008 May;179(5):1804-9; discussion 1809-10. doi: 10.1016/j.juro.2008.01.013. Epub 2008 Mar 18. J Urol. 2008. PMID: 18353398

2

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.

Davis JW, Nakanishi H, Kumar VS, Bhadkamkar VA, McCormack R, Fritsche HA, Handy B, Gornet T, Babaian RJ. Davis JW, et al. Among authors: fritsche ha. J Urol. 2008 Jun;179(6):2187-91; discussion 2191. doi: 10.1016/j.juro.2008.01.102. Epub 2008 Apr 18. J Urol. 2008. PMID: 18423725

3

Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.

Naya Y, Fritsche HA, Cheli CD, Stamey TA, Bartsch G, Brawer MK, Childs S, Taneja SS, Lepor H, Partin AW, Sokoll LJ, Chan DW, Babaian RJ. Naya Y, et al. Among authors: fritsche ha. Urology. 2003 Dec;62(6):1058-62. doi: 10.1016/j.urology.2003.07.016. Urology. 2003. PMID: 14665355

4

Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.

Naya Y, Fritsche HA, Bhadkamkar VA, Mikolajczyk SD, Rittenhouse HG, Babaian RJ. Naya Y, et al. Among authors: fritsche ha. Urology. 2004 Mar;63(3):492-8. doi: 10.1016/j.urology.2003.10.044. Urology. 2004. PMID: 15028444

5

Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer.

Naya Y, Fritsche HA, Bhadkamkar VA, Mikolajczyk SD, Rittenhouse HG, Babaian RJ. Naya Y, et al. Among authors: fritsche ha. Urol Oncol. 2005 Jan-Feb;23(1):16-21. doi: 10.1016/j.urolonc.2004.07.017. Urol Oncol. 2005. PMID: 15885578

6

Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.

Ochiai A, Fritsche HA, Babaian RJ. Ochiai A, et al. Among authors: fritsche ha. Urology. 2005 Oct;66(4):819-23. doi: 10.1016/j.urology.2005.04.040. Urology. 2005. PMID: 16230145

7

The detection and potential economic value of complexed prostate specific antigen as a first line test.

Babaian RJ, Naya Y, Cheli C, Fritsche HA. Babaian RJ, et al. Among authors: fritsche ha. J Urol. 2006 Mar;175(3 Pt 1):897-901; discussion 901. doi: 10.1016/S0022-5347(05)00343-5. J Urol. 2006. PMID: 16469574

8

Is there a role for serum human tissue kallikrein in detection of prostate cancer?

Ochiai A, Shukla A, Davis JW, Fritsche HA, Bhadkamkar V, Babaian RJ. Ochiai A, et al. Among authors: fritsche ha. Urology. 2007 Sep;70(3):519-22. doi: 10.1016/j.urology.2007.04.036. Urology. 2007. PMID: 17905108

9

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.

Babaian RJ, Fritsche H, Ayala A, Bhadkamkar V, Johnston DA, Naccarato W, Zhang Z. Babaian RJ, et al. Urology. 2000 Dec 20;56(6):1000-6. doi: 10.1016/s0090-4295(00)00830-x. Urology. 2000. PMID: 11113747

10

Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.

Okihara K, Fritsche HA, Ayala A, Johnston DA, Allard WJ, Babaian RJ. Okihara K, et al. Among authors: fritsche ha. J Urol. 2001 Jun;165(6 Pt 1):1930-6. doi: 10.1097/00005392-200106000-00021. J Urol. 2001. PMID: 11371884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters